Jeremy Springhorn
Director/Board Member chez UNIQURE N.V.
Fortune : 89 892 $ au 31/03/2024
Profil
Jeremy P.
Springhorn is currently the Chief Executive Officer & Director at Nido Biosciences, Inc. He is also serving as the Director-Fundraising & Development at Juvenile Diabetes Research Foundation Canada.
Additionally, he holds the position of Independent Non-Executive Director at uniQure NV since 2017 and Non-Executive Director at NMD Pharma A since 2019.
Dr. Springhorn is a Member of the Licensing Executives Society and the Biotechnology Innovation Organization.
He is also a Member of the Visitors Board at Colby College.
In his former roles, Dr. Springhorn served as the Senior Director at Protein Therapeutics, Inc. and as the Director at Mythic Therapeutics, Inc. He was the VP-Corporate Strategy & Business Development at Alexion Pharmaceuticals, Inc. from 2009 to 2015.
From 2015 to 2017, he worked as a Partner & Head of Corporate Development at Flagship Pioneering.
Dr. Springhorn also served as the Chief Business Officer at Syros Pharmaceuticals, Inc. from 2017 to 2021.
He completed his undergraduate degree at Colby College in 1984 and obtained his doctorate from Louisiana State University in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
UNIQURE N.V.
0,04% | 15/09/2023 | 17 287 ( 0,04% ) | 89 892 $ | 31/03/2024 |
Postes actifs de Jeremy Springhorn
| Sociétés | Poste | Début |
|---|---|---|
| UNIQURE N.V. | Director/Board Member | 14/09/2017 |
Juvenile Diabetes Research Foundation Canada
 Juvenile Diabetes Research Foundation Canada Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation Canada focuses on type 1 diabetes (T1D) research. The company was founded in 1974 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 07/06/2010 |
| Licensing Executives Society | Corporate Officer/Principal | 07/06/2010 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | 07/06/2010 |
| Colby College | Corporate Officer/Principal | 01/06/2017 |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Director/Board Member | 01/01/2019 |
Nido Biosciences, Inc.
 Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Chief Executive Officer | - |
Anciens postes connus de Jeremy Springhorn
| Sociétés | Poste | Fin |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2021 |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | 01/06/2017 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Jeremy Springhorn
| Colby College | Undergraduate Degree |
| Louisiana State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| UNIQURE N.V. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Protein Therapeutics, Inc.
 Protein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protein Therapeutics, Inc. developed pharmaceuticals. The company was headquartered in Tucson, AZ. | Health Technology |
| Licensing Executives Society | |
Juvenile Diabetes Research Foundation Canada
Juvenile Diabetes Research Foundation Canada Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation Canada focuses on type 1 diabetes (T1D) research. The company was founded in 1974 and is headquartered in Toronto, Canada. | Commercial Services |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Health Technology |
Mythic Therapeutics, Inc.
 Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Health Technology |
Nido Biosciences, Inc.
Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Health Technology |
| Arradial, Inc. |
